Detalhe da pesquisa
1.
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study).
Am J Respir Crit Care Med
; 205(10): 1214-1227, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35175905
2.
QT Interval Prolongation in People Treated With Bedaquiline for Drug-Resistant Tuberculosis Under Programmatic Conditions: A Retrospective Cohort Study.
Open Forum Infect Dis
; 8(8): ofab413, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34466629